A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Clinical trial NCT05156983 · RECRUITING

Trial details

NCT number: NCT05156983
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Coagulation Disorder

Start date: 2022-08-24
Primary completion: 2028-08-30
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.